Browse articles from EyeWorld.org related to IOLs. EyeWorld is the award-winning member publication of ASCRS. The magazine provides news and updates from the Society as well as clinical features in the areas of cataract, refractive, cornea, glaucoma, and practice management. It publishes quarterly with editorial direction from its medical editorial board and staff.
There is often discussion about the conditions an eye should meet in order to be successful with a premium, advanced technology IOL, but what about patients who desire independence from spectacles but who have less than perfect eyes? With more options available in the presbyopia-correcting IOL market, some can be suitable even if the patient has existing ocular pathology.
EyeWorld looks back on key milestones in the magazine’s history and in ophthalmology as it celebrates 25 years.
Two surgeons shared how they educate patients about the options available and the process they use to choose a lens.
The Light Adjustable Lens (LAL, RxSight) offers the unique opportunity to lock in the preferred vision after surgery. With recent updates, the technology can be an attractive option for a variety of refractive cataract patients. Several surgeons discussed how they use this IOL in their practice.
The large number of patients worldwide with presbyopia creates a unique opportunity for eyecare providers to improve patients’ quality of life, according to George Waring IV, MD, FACS. He and Shamik Bafna, MD, discussed some of the surgical and pharmacological options.
This “YES connect” column examined trifocal, combined multifocal-EDOF, and accommodating technology on the horizon with input from three experts.
➤ Full results from Phase 3 study for presbyopia-correcting eye drop ➤ Cells from two donors treat dozens of patients with corneal endothelial disease ➤ Study: Dry eye treatment reduces halos after cataract surgery ➤ NDA accepted for IND application for novel, investigational dry eye drug ➤ Acquisition of ophthalmic drug candidate ➤ ASCRS events
Sessions on Monday at the ASCRS Annual Meeting included the Innovators General Session, the Winning Pitch Challenge, and various other symposia. The ASOA Annual Meeting held its second General Session.
➤ FDA grants IDE for MIGS device to start pivotal trial ➤ Breakthrough therapy designation granted for possible Stargardt treatment ➤ Refractive surgery uptick continues ➤ First patient dosed in trial for light-activated optogenetic monotherapy for RP ➤ Diagnostic device company acquires ophthalmic device manufacturer ➤ Two ophthalmic companies partner ➤ ASCRS news and events
Sabrina Mukhtar, MD, ophthalmology resident, University of Pittsburgh, provides a summary of “Glued intraocular lens in eyes with deficient capsules: retrospective analysis of long-term effects” from the April issue of the Journal of Cataract & Refractive Surgery.